BridgeMD
New treatment option for HIV-1-infection
Official title Cannabis Use, Cognition, and the Endocannabinoid System in HIV
ClinicalTrials.gov ID: NCT04883255
What this study is testing
What is 10 mg Δ9-tetrahydrocannabinol (THC)?
10 mg Δ9-tetrahydrocannabinol (THC) is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for hiv-1-infection.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Understanding how co-morbidities in persons with HIV (PWH) such as substance use affect risk-taking, decision-making, and other cognitive behaviors is important given implications for everyday functioning and transmission risk. The high prevalence of cannabis use in PWH, medicinally and recreationally, may indicate disease severity, impart therapeutic benefits, or adverse consequences.
- Phase 1: an early, usually small safety study
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65. Healthy volunteers may be eligible.
You may be able to join if
- Aged 18-65
- Possess the capacity to provide informed consent to a set of neurobehavioral, neuromedical and cognitive assessment procedures. Individuals unable to...
- Willing to confirm self-reported HIV using a rapid test: HIV status will be determined using the MedMira Rapid Test (Halifax, Nova Scotia, Canada)...
- Willing to abstain from cannabis for at least 1 week prior to the baseline visit and during the study. Although there is no definitive method for...
You likely can't join if
- Inability to provide informed consent
- Significant chronic renal disease (unrelated to HIV), significant chronic pulmonary disease (unrelated to HIV), or Hepatitis C Virus infection
- Head injury with loss of consciousness for greater than 30 minutes or resulting in neurologic complications
- Seizure disorder
- Demyelinating diseases or other non-HIV neurological disorders
- Pregnancy
See the full eligibility criteria
- Aged 18-65
- Possess the capacity to provide informed consent to a set of neurobehavioral, neuromedical and cognitive assessment procedures. Individuals unable to provide such consent will not be enrolled into the study.
- Willing to confirm self-reported HIV using a rapid test: HIV status will be determined using the MedMira Rapid Test (Halifax, Nova Scotia, Canada). If the result differs from the participant's self-report a confirmatory...
- Willing to abstain from cannabis for at least 1 week prior to the baseline visit and during the study. Although there is no definitive method for determining abstinence over this period, abstinence will be confirmed as...
- Inability to provide informed consent
- Significant chronic renal disease (unrelated to HIV), significant chronic pulmonary disease (unrelated to HIV), or Hepatitis C Virus infection
- Head injury with loss of consciousness for greater than 30 minutes or resulting in neurologic complications
- Seizure disorder
- Demyelinating diseases or other non-HIV neurological disorders
- Pregnancy
- Acute or recent or previous clinically disabling stroke or previous cerebrovascular events
- Lifetime history of schizophrenia or other psychotic disorders, or bipolar disorder.
- Beck Depression Inventory-II (BDI-II) score is greater than or equal to 29 (severe depression) or suicidal ideas are endorsed on the BDI-II or a Center for Epidemiological Studies-Depression Scale (CES-D) subscale...
- Substance use disorder (mild, moderate or severe) within the last 12 months
The study team makes the final eligibility decision.
Where it's taking place
- San Diego, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include San Diego, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.